Is acalabrutinib chemo?

Acalabrutinib is an oral chemotherapy medication designed to cause cancerous B-lymphocytes to leave the bone marrow and lymph nodes and enter the bloodstream where they die more quickly.

Is CALQUENCE considered chemotherapy?

How CALQUENCE Works. CALQUENCE is a targeted alternative to traditional chemotherapy for patients with CLL/SLL. It can be used for patients who have already received another treatment. CALQUENCE is a kinase inhibitor that affects the growth of CLL/SLL cancer cells.

What kind of drug is acalabrutinib?

Acalabrutinib is a type of targeted cancer drug called a bruton tyrosine kinase inhibitor. Tyrosine kinase inhibitors (TKIs) block chemical messengers (enzymes) called tyrosine kinases. Tyrosine kinases help to send growth signals in cells, so blocking them stops the cell from growing and dividing.

Is acalabrutinib an immunotherapy?

Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

Can acalabrutinib cure CLL?

Treatment with the next-generation covalent Bruton tyrosine kinase (BTK) inhibitor acalabrutinib was safe and led to durable, long-term remission in a small group of patients with previously untreated chronic lymphocytic leukemia (CLL), according to a study published in Blood.

ASCEND-ing results: acalabrutinib is well-tolerated and highly effective in R/R CLL

What is the newest treatment for CLL?

In May 2019, the FDA approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) to treat people with previously untreated CLL as a chemotherapy-free option. In April 2020, the FDA approved a combination therapy of rituximab (Rituxan) and ibrutinib (Imbruvica) for adult patients with chronic CLL.

Is acalabrutinib better than ibrutinib?

Abstract. Purpose: Among Bruton's tyrosine kinase inhibitors, acalabrutinib has greater selectivity than ibrutinib, which we hypothesized would improve continuous therapy tolerability.

Does acalabrutinib affect immune system?

It is currently unclear whether the positive effects of ibrutinib on the immune system are sustained during long-term therapy. Acalabrutinib is a newer, more selective BTK inhibitor than ibrutinib; however a detailed evaluation of the immunologic impact of acalabrutinib therapy is lacking.

Can Calquence cure CLL?

In the final analysis of ASCEND, an estimated 82% of patients with relapsed or refractory CLL treated with Calquence remained alive and free from disease progression at 18 months compared with 48% of patients on rituximab combined with idelalisib or bendamustine.

What are the side effects of acalabrutinib?

Does acalabrutinib cause hair loss?

Hair loss does not occur with acalabrutinib.

Is Obinutuzumab chemotherapy?

Obinutuzumab is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Obinutuzumab is classified as a "monoclonal antibody" (For more detail, see "How Obinutuzumab Works" section below).

How long do you take acalabrutinib?

Acalabrutinib in Combination with Obinutuzumab: For patients with previously untreated CLL or SLL, the recommended dose is 100 mg taken orally approximately every 12 hours until disease progression or unacceptable toxicity. Start acalabrutinib at cycle 1 (each cycle is 28 days).

What type of drug is CALQUENCE?

Generic Name: acalabrutinib

This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors.

Is CALQUENCE a biologic?

CALQUENCE® (acalabrutinib) Approved for Previously-Treated Mantle Cell Lymphoma, Available for Order at Biologics, Inc.

How good is Acalabrutinib?

The overall response rate for patients receiving acalabrutinib was observed at 73% (95% CI, 60%-84%), with 3 patients experiencing a complete response (CR) to treatment.

Can you drink beer while taking Calquence?

Alcohol use and Calquence

There's no known interaction between alcohol and Calquence. But if you're taking Calquence with Gazyva (obinutuzumab) for chronic lymphocytic leukemia or small lymphocytic lymphoma, you should avoid alcohol.

Can Calquence cause weight gain?

What are the most common side effects from acalabrutinib (Calquence^®) therapy for CLL? In clinical studies, the most commonly reported side effects of acalabrutinib are shown here. Side effects sometimes have percentage ranges [example: 22 – 43%] because they differed between clinical studies: Weight gain.

Is CLL an immunosuppressive disease?

Chronic lymphocytic leukemia (CLL) is a type of cancer that attacks white blood cells, affecting your body's ability to fight off infection. CLL leaves you immunocompromised, increasing your risk of infection, other cancers, autoimmune conditions, and severe complications from COVID-19.

Can I take ibuprofen with acalabrutinib?

Do not take aspirin (salicylic acid), non-steroidal, anti-inflammatory medications (NSAIDs) such as Motrin/Advil (ibuprofen), Aleve (naproxen), Celebrex (celecoxib), etc. as these can all increase the risk of bleeding.

Does CLL compromise your immune system?

People with CLL usually have a weakened immune system and are more vulnerable to infections because they have a lack of healthy infection-fighting white blood cells. Treatment with chemotherapy can also further weaken the immune system.

Can ibrutinib cause kidney failure?

Despite the fact that less than 10% of ibrutinib is excreted by kidneys, increase in creatinine level 1.5 to 3 times the upper limit of normal occurs in up to 9% of patients during treatment⁴ and occasionally patients were developed serious renal failure.

Is there an alternative to ibrutinib?

This finding suggests that acalabrutinib is a well-tolerated alternative for patients who have developed an intolerance to ibrutinib, says Leslie.

Does ibrutinib cause weight loss?

The drug ibrutinib is a highly effective treatment for people with chronic lymphocytic leukemia (CLL), but a new Wilmot Cancer Institute study shows that weight gain, as a drug side effect, should be closely managed to prevent other health problems.